OptimizeRx Corporation announced the acquisition of RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity. The RMDY Health platform is used by pharmaceutical companies, payers, MedTech companies, and medical associations nationwide. The acquisition adds three new client segments to OptimizeRx’s existing consumer engagement platform – payers, medtech, and medical associations – further simplifying chronic disease management and drug adherence for healthier results at lower costs.
OptimizeRx is a recognized leader in bridging the communication gap between pharmaceutical companies and provider organizations with its digital health messaging platform delivered through its nationwide network of leading electronic health record (EHR) and ePrescribing provider organizations. The addition of RMDY Health expands the reach of this network by using consumer apps and web access as an additional channel for digital heath messaging.
This strategic acquisition is the second for OptimizeRx over the past year focused on enhancing consumer engagement. It further diversifies the company’s recurring revenue stream and scales its solution set to better address larger opportunities in digital health. RMDY will maintain its technology team in Tel Aviv, Israel, and U.S. based personnel. Additionally, the company will use the OptimizeRx New Jersey headquarters.
Digital therapeutics (DTx) consists of delivering rich consumer programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms and surveys, with this all supported by a wide range of communication capabilities delivered via chat, bots, audio and telehealth. RMDY Health enables this functionality for its customers, with its DTx solutions delivering a variety of intervention mechanisms that help treat chronic conditions, such as diabetes and heart disease.
RMDY Health is a leading provider organization of collaborative digital therapeutics SaaS solutions for the health care industry. Its SaaS platform offers a complete digital framework to help life science and health care stakeholders rapidly and effortlessly design and launch their own white-label collaborative digital care and consumer support programs. The company’s web and mobile platform supports a wide range of digital therapeutic initiatives, with a focus on care management, chronic disease management, consumer support programs, research, and wellness.
OptimizeRx, a digital health company, connects pharmaceutical companies to consumers and provider organizations, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation’s largest point-of-prescribe promotional platform for the pharmaceutical industry, OptimizeRx provides a direct channel for pharma companies to communicate with health care provider organizations right within their workflow and also directly to consumers.
This was reported by OptimizeRx on September 5, 2019.
Contact information: RMDY Health, 336 Atlantic Avenue, Suite 301 East Rockaway, New York 11518; Website: www.rmdy.health
Contact information: Doug Baker, Chief Financial Officer, OptimizeRx, 400 Water Street, Suite 200, Rochester, Michigan 48307; 248-651-6568, Ext. 807; Email: firstname.lastname@example.org; Website: www.optimizerx.com